큐리오시스

494120· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩10,570+19.30%

2026-11-02

Financials

Valuation Metrics

큐리오시스's Market Cap is ₩1613B. Ranked #925 of 2,405 in KR market (top 38%), #440 of 1,627 on KOSDAQ (top 27%), #108 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 47%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	161.30B KRW	KR#925/2,405 Sec#108/231
Revenue	8.38B KRW	KR#2,288/2,405 Sec#180/231
Net Income	-7.89B KRW	KR—/2,405 Sec—/231
Total Assets	31.94B KRW	KR#2,315/2,405 Sec#220/231
Net Assets	24.72B KRW	KR#2,222/2,405 Sec#206/231
Value
P/B	6.52x	KR#2,302/2,405 Sec#200/231
P/S	19.26x	KR#2,326/2,405 Sec#185/231
FCF Yield	-5.94%	KR—/2,405 Sec—/231
Profitability
ROE	-31.91%	KR#2,188/2,405 Sec#180/231
ROA	-24.69%	KR#2,265/2,405 Sec#188/231
Op. Margin	-93.67%	KR#2,280/2,405 Sec#171/231
Financial Health
Debt Ratio	29.21%	KR#562/2,405 Sec#64/231
Total Debt	2.77B KRW	KR#1,866/2,405 Sec#180/231
FCF	-9.58B KRW	KR#1,689/2,405 Sec#146/231
Cash	17.04B KRW	KR#1,349/2,405 Sec#106/231
Current Ratio	6.00x	KR#214/2,405 Sec#43/231
Performance
1M Return	8.41%	KR#122/2,405 Sec#11/231
From 52W High	-78.08%	KR#2,258/2,405 Sec#204/231
1Y MDD	-84.07%	KR#2,332/2,405 Sec#219/231
Trading
Volume	195,127 shares	KR#390/2,405 Sec#36/231
Trading Value	1.97B KRW	KR#435/2,405 Sec#41/231
Foreign Own.	5.96%	KR#734/2,405 Sec#66/231
Per Share
EPS	-517 KRW	KR—/2,405 Sec—/231
BPS	1,620 KRW	KR#2,161/2,405 Sec#183/231